LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver
Open Access
- 4 October 2025
- journal article
- Published by Wiley in Advanced Materials
- Vol. 38 (7) , e06373
Abstract
Excessive lipid droplet accumulation in hepatocytes drives the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD), often leading to inflammation and fibrosis. As obesity and metabolic syndrome rise, MASLD has become a global concern, spurring research into effective treatments. Here, the design of a Lipid droplet inhibitor (LDI) is presented, incorporating porous silica nanostructures along with PKCα C1A and Candida Rugosa lipase, aimed at directly degrading lipid droplets. Through its dual‐functional design, this nanostructure captures diacylglycerol using PKCα C1A while hydrolyzing triacylglycerol into smaller molecular fragments via the lipase. Notably, the amphiphilic biomolecules in LDI facilitate the formation of a Pickering emulsion, ensuring stable localization at the lipid‐water interface for efficient interaction with lipid droplets. LDI reduces lipid droplet formation and triglyceride levels in palmitic acid‐treated HepG2 cells. In a high‐fat diet‐induced MASLD model, it alleviateds liver pathology and, lowered injury scores by up to 84%. Furthermore, lipidomic analysis confirmed that LDI effectively modulated the hepatic lipid profile, suggesting its potential as a nanoplatform for counteracting lipid droplet accumulation.Keywords
Funding Information
- Korea Institute of Science and Technology (2E33742)
- Ministry of Food and Drug Safety (RS‐2024‐00332024,23212MFDS2023)
- Ministry of Science and ICT, South Korea (2023R1A2C2003128,2022R1A2C1092294)
This publication has 63 references indexed in Scilit:
- Fatty Liver/Adipose Tissue Dual‐Targeting Nanoparticles with Heme Oxygenase‐1 Inducer for Amelioration of Obesity, Obesity‐Induced Type 2 Diabetes, and SteatohepatitisAdvanced Science, 2022
- Pickering Emulsion Catalysis: Interfacial Chemistry, Catalyst Design, Challenges, and PerspectivesAngewandte Chemie International Edition, 2022
- Flexible 3D Nanonetworked Silica Film as a Polymer‐Free Drug‐Eluting Stent Platform to Effectively Suppress Tissue Hyperplasia in Rat EsophagusAdvanced Healthcare Materials, 2022
- Aggregating particles on the O/W interface: Tuning Pickering emulsion for the enhanced drug delivery systemsAggregate, 2022
- Revamping SiO2 Spheres by Core–Shell Porosity Endowment to Construct a Mazelike Nanoreactor for Enhanced Catalysis in CO2 Hydrogenation to Methanol (Adv. Funct. Mater. 47/2021)Advanced Functional Materials, 2021
- Enzyme Conformation Influences the Performance of Lipase‐powered NanomotorsAngewandte Chemie International Edition, 2020
- Lipase‐Powered Mesoporous Silica Nanomotors for Triglyceride DegradationAngewandte Chemie International Edition, 2019
- Degradable Nanoparticles Restore Lysosomal pH and Autophagic Flux in Lipotoxic Pancreatic Beta CellsAdvanced Healthcare Materials, 2019
- Nonalcoholic Fatty Liver DiseaseJAMA, 2015
- Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytesHepatology, 2007